Efficacy of Lipid-Lowering Therapy during Cardiac Rehabilitation in Patients with Diabetes Mellitus and Coronary Heart Disease.

Thomas WittlingerBernhard SchwaabHeinz VöllerChrista BongarthViktoria HeinzeKristina EckrichManju GuhaMichael RichterAxel Schlitt

Published in: Journal of cardiovascular development and disease (2021)

Within 3 months after CR, total and LDL cholesterol were significantly reduced, irrespective of prevalent diabetes mellitus. In addition, CHD patients with diabetes responded faster to LTT than nondiabetic patients, suggesting that diabetic patients benefit more from LLT treatment during CR.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
type diabetes
glycemic control
stem cells
patient reported outcomes
fatty acid
patient reported